About Tektin-1
Tektin-1 (TEKT1) is a protein
from Homo sapiens identified by UniProt accession
Q969V4, 418 residues long.
MolForge cross-references it against 0 known binders and
28 disease associations.
Target properties
| Protein name | Tektin-1 |
| UniProt accession | Q969V4 |
| Gene | TEKT1 |
| Organism | Homo sapiens |
| Length | 418 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (28)
Diseases linked to this target (Open Targets).
- influenza A (H1N1) · score 0.24
- late-onset Alzheimers disease · score 0.14
- blood metabolite measurement · score 0.08
- neutrophil count · score 0.06
- Hepatic veno-occlusive disease - immunodeficiency · score 0.04
- immunodeficiency 75 · score 0.03
- autoinflammation with episodic fever and lymphadenopathy · score 0.03
- proteasome-associated autoinflammatory syndrome 4 · score 0.03
- central nervous system cancer · score 0.03
- ependymoma · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q969V4-F1 | alphafold | PREDICTED | 92.86 | — |
Amino-acid sequence (418 residues)
MAKLLQPPPK FLPSEWHIAN KNQYHRADAQ RSRSERLVAE SQRLVDEIEK TTRKSQSDVN KKLEQRLEEV QFWKKELDDK LEQLVNVTDD LLIYKIRLEK ALETLKEPLH ITETCLAYRE KRIGIDLVHD TVEHELIKEA EIIQGIMALL TRTLEEASEQ IRMNRSAKYN LEKDLKDKFV ALTIDDICFS LNNNSPNIRY SENAVRIEPN SVSLEDWLDF SSTNVEKADK QRNNSLMLKA LVDRILSQTA NDLRKQCDVV DTAFKNGLKD TKDARDKLAD HLAKVMEEIA SQEKNITALE KAILDQEGPA KVAHTRLETR THRPNVELCR DVAQYRLMKE VQEITHNVAR LKETLAQAQA ELKGLHRRQL ALQEEIQVKE NTIYIDEVLC MQMRKSIPLR DGEDHGVWAG GLRPDAVC
Explore Tektin-1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets